Grant Verstandig, Director at NexImmune, Inc. (NEXI), bought 381,200 shares at $3.76 ($1.5M) on 2022-03-28, disclosed to the SEC on 2022-03-28.
Open-market purchase of $1.5M NEXI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.35 | 39,995 | $134K | 8.9% |
| 2 | $3.35 | 39,995 | $134K | 8.9% |
| 3 | $4.14 | 131,622 | $545K | 36.3% |
| 4 | $4.14 | 131,622 | $545K | 36.3% |
| 5 | $3.76 | 18,983 | $71K | 4.8% |
| 6 | $3.76 | 18,983 |
| $71K |
| 4.8% |
| Total | $3.94 avg | 381,200 | $1.5M | 100% |
| Filing → |
| NEXI | BUY | 2021-02-19 | $3.0M | — | Filing → |